Randomised controlled trial · 2025
Comparative efficacy of EMLA cream, lidocaine spray, and benzocaine condoms in treating lifelong premature ejaculation: a randomized clinical study
Hamarat MB, Kafkaslı A, Kucuktopcu O, Ecer G, Yazıcı Ö, Karataş B (2025). Comparative efficacy of EMLA cream, lidocaine spray, and benzocaine condoms in treating lifelong premature ejaculation: a randomized clinical study. World Journal of Urology. doi:10.1007/s00345-025-06015-3
In 273 men with lifelong PE assigned to lidocaine spray, lidocaine–prilocaine (EMLA) cream or benzocaine condoms, all three lengthened latency; the spray gave the largest gain and the condoms the smallest, with the fewest side effects.
Summary
This randomised study from Turkey compared three common topical options for lifelong premature ejaculation (PE), as defined by the International Society for Sexual Medicine. It included 273 men attending an andrology clinic, who were randomized to lidocaine–prilocaine cream (EMLA, 59 men), a lidocaine spray (126 men) or benzocaine condoms (88 men). Intravaginal ejaculatory latency time (IELT: the time from penetration to ejaculation) was recorded before and after treatment.
Latency increased significantly in all three groups. The largest increase was with the lidocaine spray, followed by the cream and then the benzocaine condoms. Side effects were minimal overall and lowest in the condom group. The authors conclude that the spray and cream lengthened latency more than benzocaine condoms in the short term.
Limitations
There was no placebo or untreated control group, so part of each improvement may reflect expectation or the passage of time. Group sizes were very unequal (59/126/88) and the allocation method is not described, so randomisation quality is unclear. The abstract does not report the latency values themselves or how they were measured. Follow-up was short, and satisfaction was not assessed.
What it means for you
For men with lifelong PE, benzocaine condoms appear to help, but less than a lidocaine spray or cream. Their advantages are convenience, fewer side effects in this study and a barrier that limits transfer to a partner. If a condom alone is not enough, a stronger topical option or other treatment is worth discussing with a doctor.